Run Lin

1.9k total citations
46 papers, 1.5k citations indexed

About

Run Lin is a scholar working on Biomedical Engineering, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Run Lin has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomedical Engineering, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Run Lin's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Nanoplatforms for cancer theranostics (5 papers). Run Lin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Nanoplatforms for cancer theranostics (5 papers). Run Lin collaborates with scholars based in China, United States and Taiwan. Run Lin's co-authors include Weiling He, Jin‐Zhi Du, Jun Wang, Hui Mao, Hongjun Li, Jing Huang, Lily Yang, Zunfu Ke, Hui Zhang and Haibo Qiu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Run Lin

43 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Run Lin China 19 413 394 390 383 360 46 1.5k
Ninh M. La‐Beck United States 19 634 1.5× 766 1.9× 504 1.3× 603 1.6× 349 1.0× 43 1.8k
Xiaoxue Xie China 28 713 1.7× 492 1.2× 330 0.8× 637 1.7× 263 0.7× 75 1.9k
Shuang Cai China 23 335 0.8× 370 0.9× 309 0.8× 815 2.1× 201 0.6× 60 1.8k
Xiao Xu China 21 475 1.2× 306 0.8× 222 0.6× 615 1.6× 164 0.5× 56 1.3k
Ketki Bhise United States 12 382 0.9× 269 0.7× 996 2.6× 560 1.5× 639 1.8× 17 2.0k
Hashem O. Alsaab Saudi Arabia 15 417 1.0× 335 0.9× 1.1k 2.8× 583 1.5× 666 1.9× 22 2.2k
Shanzhou Duan China 19 302 0.7× 207 0.5× 261 0.7× 529 1.4× 141 0.4× 40 1.2k
Rami M. Alzhrani Saudi Arabia 18 558 1.4× 320 0.8× 986 2.5× 562 1.5× 634 1.8× 64 2.4k
Chao Qin China 24 370 0.9× 424 1.1× 231 0.6× 672 1.8× 121 0.3× 69 1.5k

Countries citing papers authored by Run Lin

Since Specialization
Citations

This map shows the geographic impact of Run Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Run Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Run Lin more than expected).

Fields of papers citing papers by Run Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Run Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Run Lin. The network helps show where Run Lin may publish in the future.

Co-authorship network of co-authors of Run Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Run Lin. A scholar is included among the top collaborators of Run Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Run Lin. Run Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Chen, Wenrui Zhao, Yong Xiang Li, et al.. (2025). How effective is acupuncture in treating hot flashes in breast cancer patients? A systematic review and meta-analysis. Frontiers in Oncology. 15. 1543938–1543938. 2 indexed citations
2.
Li, Han, Run Lin, Yanna Zhang, et al.. (2024). N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation. Molecular Cancer. 23(1). 5–5. 22 indexed citations
3.
Chen, Jinhao, et al.. (2024). Endoplasmic reticulum stress-related gene expression causes the progression of dilated cardiomyopathy by inducing apoptosis. Frontiers in Genetics. 15. 1366087–1366087. 1 indexed citations
4.
5.
Zhang, Weihang, et al.. (2023). Liquid nitric oxide donor for adjuvant therapy of acute ischemic stroke via nasal administration. Nitric Oxide. 134-135. 72–78. 5 indexed citations
6.
Chen, Bin, Run Lin, Haitao Dai, et al.. (2023). XperCT facilitates sharp recanalization for the treatment of chronic thoracic venous occlusive disease in hemodialysis patients. The Journal of Vascular Access. 25(4). 1129–1133. 4 indexed citations
7.
Chen, Bin, Haitao Dai, Jianyong Yang, et al.. (2023). Transarterial Chemoembolization Followed by Hepatic Arterial InfusionChemotherapy Combined a Tyrosine Kinase Inhibitor for Treatment ofLarge Hepatocellular Carcinoma. Current Cancer Drug Targets. 23(7). 564–571. 7 indexed citations
8.
Lin, Run, et al.. (2023). Thermosensitive selenium hydrogel boosts antitumor immune response for hepatocellular carcinoma chemoradiotherapy. Nano Today. 50. 101823–101823. 25 indexed citations
9.
Zhang, Guiyuan, et al.. (2023). Inducing the Abscopal Effect in Liver Cancer Treatment: The Impact of Microwave Ablation Power Levels and PD-1 Antibody Therapy. Pharmaceuticals. 16(12). 1672–1672. 7 indexed citations
10.
Chang, Ying, Ying Zhang, Yifan Bai, et al.. (2023). The correlation between tic disorders and allergic conditions in children: A systematic review and meta-analysis of observational studies. Frontiers in Pediatrics. 11. 1064001–1064001. 6 indexed citations
11.
Chen, Bin, Haitao Dai, Jianyong Yang, et al.. (2022). Computational fluid dynamics simulation of hemodynamic changes in a hemodialysis patient with central venous stenosis treated with stent. Seminars in Dialysis. 35(6). 528–533. 3 indexed citations
12.
Chen, Bin, Run Lin, Haitao Dai, et al.. (2022). Clinical Implications of Phenotypes of Hemodialysis Patients With Central Venous Occlusion or Central Venous Stenosis Defined by Cluster Analysis. Frontiers in Cardiovascular Medicine. 9. 901237–901237. 3 indexed citations
13.
Zhang, Guiyuan, et al.. (2022). Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of Literature. Frontiers in Oncology. 12. 785888–785888. 1 indexed citations
14.
Chen, Bin, Run Lin, Haitao Dai, et al.. (2021). Sharp recanalization for treatment of central venous occlusive disease in hemodialysis patients. Journal of Vascular Surgery Venous and Lymphatic Disorders. 10(2). 306–312. 21 indexed citations
15.
Lin, Run, Hui Zhang, Yujie Yuan, et al.. (2020). Fatty Acid Oxidation Controls CD8+ Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma. Cancer Immunology Research. 8(4). 479–492. 169 indexed citations
16.
17.
Lin, Run, et al.. (2017). Transient Stability Study of Power System with Large-Scale Wind Farm Integration. Energy and Power Engineering. 9(4). 552–561. 2 indexed citations
18.
Li, Nan, Bin Chen, Run Lin, et al.. (2017). The earlier, the better: the effects of different administration timepoints of sorafenib in suppressing the carcinogenesis of VEGF in rats. Cancer Chemotherapy and Pharmacology. 81(1). 207–216. 4 indexed citations
19.
Lin, Run, Yuancheng Li, Tobey J. MacDonald, et al.. (2016). Improving sensitivity and specificity of capturing and detecting targeted cancer cells with anti-biofouling polymer coated magnetic iron oxide nanoparticles. Colloids and Surfaces B Biointerfaces. 150. 261–270. 37 indexed citations
20.
Huang, Jing, Liya Wang, Run Lin, et al.. (2013). Casein-Coated Iron Oxide Nanoparticles for High MRI Contrast Enhancement and Efficient Cell Targeting. ACS Applied Materials & Interfaces. 5(11). 4632–4639. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ninh M. La‐Beck Breakdown of academic impact, for papers by Xiaoxue Xie Breakdown of academic impact, for papers by Shuang Cai Breakdown of academic impact, for papers by Xiao Xu Breakdown of academic impact, for papers by Ketki Bhise Breakdown of academic impact, for papers by Hashem O. Alsaab Breakdown of academic impact, for papers by Shanzhou Duan Breakdown of academic impact, for papers by Rami M. Alzhrani Breakdown of academic impact, for papers by Chao Qin
Rankless by CCL
2026